Lymphoma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People whose transplant information is registered with the Center for International Blood and Marrow Transplant Research (CIBMTR), a large research database for blood and marrow transplant patients
- Adults aged 18 or older who have been diagnosed with either Cutaneous T-Cell Lymphoma (CTCL) or Adult T-Cell Leukemia/Lymphoma (ATLL), which are types of blood cancers affecting certain white blood cells
- People who received an allogeneic stem cell transplant (a transplant using cells from a donor) from January 2012 onwards
Who may not be able to join:
- People who have not given consent for their information to be used in research
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 414-805-0714
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Assess toxicities or complications of transplant among patients who were treated with mogamulizumab, alone or in combination
Can't join this trial?
Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.